| Name | Title | Contact Details |
|---|
Intrigma is a leader in medical scheduling solutions that deliver bottom-line impact to medical groups, hospitals and hospital systems.
DoseCue, LLC is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Genetics and IVF Institute is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Genetics and IVF Institute is based in Fairfax, VA. You can find more information on Genetics and IVF Institute at www.givf.com
Mary Free Bed Rehabilitation Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Mary Free Bed Rehabilitation Hospital is based in Grand Rapids, MI. You can find more information on Mary Free Bed Rehabilitation Hospital at www.maryfreebed.com
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.